“…Compared with parotidectomy, the incidence of facial nerve injury for treatment of vascular malformations is higher, reported at 9% compared with 5%. 1,2 Other treatment modalities, including sclerotherapy, are not without risk to the branches of the facial nerve, and injury rates can be higher than with surgical excision, especially in the region of the zygomatic branch. 3,4 Although it is understood that the risk of posttreatment facial nerve dysfunction is high after vascular anomaly treatment, particularly lymphatic malformations, facial nerve functional outcomes have not been consistently reported, and now the importance of including these outcomes in treatment reports is recognized.…”